Welcome to LookChem.com Sign In|Join Free
  • or
2,3,4,6-tetra-O-benzoyl-β-D-glucopyranosyl-(1→4)-(1,2,3,6-tetra-O-benzoyl)-β-D-glucopyranose is a complex organic compound consisting of two β-D-glucopyranose units linked through a glycosidic bond at the 1 and 4 positions. Each glucose unit is heavily modified with benzoyl groups, which are aromatic rings derived from benzoic acid. Specifically, the first glucose unit has benzoyl groups at the 2, 3, 4, and 6 positions, while the second glucose unit has benzoyl groups at the 1, 2, 3, and 6 positions. 2,3,4,6-tetra-O-benzoyl-β-D-glucopyranosyl-(1→4)-(1,2,3,6-tetra-O-benzoyl)-β-D-glucopyranose is significant in the field of carbohydrate chemistry, particularly in the synthesis of complex oligosaccharides and glycoconjugates, due to its protected structure that allows for controlled chemical reactions. The benzoyl groups serve as temporary protecting groups that can be removed under specific conditions to reveal the underlying hydroxyl groups, facilitating further chemical modifications or the formation of glycosidic bonds with other molecules.

4710-82-1

Post Buying Request

4710-82-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

4710-82-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 4710-82-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,7,1 and 0 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 4710-82:
(6*4)+(5*7)+(4*1)+(3*0)+(2*8)+(1*2)=81
81 % 10 = 1
So 4710-82-1 is a valid CAS Registry Number.

4710-82-1Relevant academic research and scientific papers

GLYCOSIDE COMPOUND AND PREPARATION METHOD THEREFOR, COMPOSITION, APPLICATION, AND INTERMEDIATE

-

Paragraph 0475-0476; 0484-0485, (2021/04/23)

The present invention discloses a glycoside compound represented by Formula III, and a preparation method, a composition, use and an intermediate thereof. The glycoside compound provided in the present invention has simple preparation method, can significantly increase the expression of VEGF-A mRNA, and is effective in promoting the angiogenesis. This provides a reliable guarantee for the development of drugs with pro-angiogenic activity for treating cerebral infarction cerebral stroke, myocardial infarction, and ischemic microcirculatory disturbance of lower limbs.

DISSACHARIDE FORMULATIONS FOR CONTROLLED DRUG RELEASE

-

Page/Page column 164; 169, (2020/12/30)

The present invention relates to a composition comprising non-water soluble dissacharides and oil, a solvent and at least one pharmaceutical ingredient, wherein the composition contains at least two compounds selected from saccharides and lipid oils such

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 4710-82-1